HMOX1 and cardiac hypertrophy: Previous studies suggest that astragaloside IV corrects cardiac dysfunction and reduces myocardial hypertrophy by activating Nrf2/HO-1 pathway and PI3K/mTOR pathway and can promote angiogenesis [37–39].